• Study on Personalized Anti-Platelet Therapy with Prasugrel, Clopidogrel, and Ticagrelor for Patients with Stable Coronary Artery Disease Undergoing Stenting

    Not recruiting

    3 1 1 1
    The Netherlands
  • Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

    Not recruiting

    2 1 1 1
    Belgium France Poland Spain
  • Study on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark Germany Portugal Sweden
  • Study of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Poland Romania Spain
  • Study on Protamine Sulfate and Sodium Chloride to Reduce Bleeding in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium The Netherlands
  • Study of ZN-c3, Encorafenib, and Cetuximab for Adults with Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Germany Hungary Italy Poland Spain
  • Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Greece Italy Spain +1
  • Study on Preventing BK Virus Infection in Kidney Transplant Patients Using Mycophenolic Acid, Mycophenolate Mofetil, and Sirolimus

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Effects of Empagliflozin on Blood Sugar Levels in Patients with HNF1A-MODY Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on Reducing Dupilumab Dose for Patients with Controlled Atopic Eczema

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

powered by